These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21621528)

  • 21. QT interval in patients with primary aldosteronism and low-renin essential hypertension.
    Maule S; Mulatero P; Milan A; Leotta G; Caserta M; Bertello C; Rabbia F; Veglio F
    J Hypertens; 2006 Dec; 24(12):2459-64. PubMed ID: 17082730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects.
    Ito Y; Takeda R; Karashima S; Yamamoto Y; Yoneda T; Takeda Y
    Hypertens Res; 2011 Jan; 34(1):98-102. PubMed ID: 20927116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laboratory diagnosis of primary aldosteronism, and drospirenone-ethinylestradiol therapy.
    Pizzolo F; Pavan C; Corrocher R; Olivieri O
    Am J Hypertens; 2007 Dec; 20(12):1334-7. PubMed ID: 18047926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. QT interval is prolonged but QT dispersion is maintained in patients with primary aldosteronism.
    Yang TY; Cheng NJ; Ko YS; Kuo CT
    Int J Clin Pract; 2007 Mar; 61(3):392-6. PubMed ID: 16749916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range.
    Tomaschitz A; Maerz W; Pilz S; Ritz E; Scharnagl H; Renner W; Boehm BO; Fahrleitner-Pammer A; Weihrauch G; Dobnig H
    J Am Coll Cardiol; 2010 May; 55(19):2171-80. PubMed ID: 20447545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The diagnosis of primary aldosteronism and separation of two major subtypes.
    Weinberger MH; Fineberg NS
    Arch Intern Med; 1993 Sep; 153(18):2125-9. PubMed ID: 8379804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Screening tests and diagnostic examinations of hypertensives for primary aldosteronism].
    Omura M; Nishikawa T
    Rinsho Byori; 2006 Nov; 54(11):1157-63. PubMed ID: 17240838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Albuminuria in untreated patients with primary aldosteronism or essential hypertension.
    Halimi JM; Mimran A
    J Hypertens; 1995 Dec; 13(12 Pt 2):1801-2. PubMed ID: 8903655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test.
    Fogari R; Preti P; Zoppi A; Rinaldi A; Fogari E; Mugellini A
    Hypertens Res; 2007 Feb; 30(2):111-7. PubMed ID: 17460380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aldosterone to renin ratio--a reliable screening tool for primary aldosteronism?
    Tomaschitz A; Pilz S
    Horm Metab Res; 2010 Jun; 42(6):382-91. PubMed ID: 20225167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
    Rossi GP; Belfiore A; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Semplicini A; Agabiti-Rosei E; Pessina AC; Mantero F;
    J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.
    Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME
    Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of a raised aldosterone-renin ratio (ARR) among new referrals to a hypertension clinic.
    Williams D; Croal B; Furnace J; Ross S; Witte K; Webster M; Critchen W; Webster J
    Blood Press; 2006; 15(3):164-8. PubMed ID: 16864158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of age, sex and BMI on the aldosterone-to-renin ratio in essential hypertensive individuals.
    Alnazer RM; Veldhuizen GP; de Leeuw PW; Kroon AA
    J Hypertens; 2023 Apr; 41(4):618-623. PubMed ID: 36723461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adiponectin and insulin sensitivity in primary aldosteronism.
    Fallo F; Della Mea P; Sonino N; Bertello C; Ermani M; Vettor R; Veglio F; Mulatero P
    Am J Hypertens; 2007 Aug; 20(8):855-61. PubMed ID: 17679033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The aldosterone to Renin ratio in secondary hypertension].
    Seiler L; Reincke M
    Herz; 2003 Dec; 28(8):686-91. PubMed ID: 14689102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Occurrence of primary aldosteronism in a group of ambulatory hypertensive patients].
    Kreze A; Okálová D; Vanuga P; Putz Z; Kodaj J; Hrnciar J
    Vnitr Lek; 1999 Jan; 45(1):17-21. PubMed ID: 10422521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in diagnosis and treatment of primary aldosteronism.
    Veglio F; Morello F; Rabbia F; Leotta G; Mulatero P
    Minerva Med; 2003 Aug; 94(4):259-65. PubMed ID: 14605590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary aldosteronism in diabetic subjects with resistant hypertension.
    Umpierrez GE; Cantey P; Smiley D; Palacio A; Temponi D; Luster K; Chapman A
    Diabetes Care; 2007 Jul; 30(7):1699-703. PubMed ID: 17429062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.